Professor David Ray鈥檚 laboratory in the Department of Biological Sciences helped identify genetic components in bats that provide insight into their immune systems.
Reinitz helped pioneer a data-driven, systems approach to developmental biology that is now widely used in the field today.
New biophysics research at the University of Miami adds to our knowledge about the origins of left-right asymmetry in the body.
A study explores how variations in the copy number of certain DNA segments can influence cognitive abilities and neurodevelopment.
Children and young people with disabilities and developmental differences represent 10 per cent of the world鈥檚 population. However, innovation in pediatric developmental health care 鈥� especially pediatric disability care -- lags behind the adult healthcare sector. One factor is due to limited access to large-scale datasets that enable ground-breaking advances in care.
For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that must be delivered by injection three-to-six times each week. Currently, patients are treated with injections of asfotase alfa, a mineral-targeted form of the missing enzyme called tissue-nonspecific alkaline phosphatase (TNAP). This FDA-approved therapy is based on a Sanford Burnham Prebys scientist鈥檚 decades of research on the TNAP enzyme and his laboratory鈥檚 studies demonstrating preclinical safety and efficacy. In a paper published January 12, 2025, in鈥痶he Journal of Bone and Mineral Research, researchers added additional weight to prior preclinical evidence of the safety and effectiveness of a gene therapy for HPP.
A Rutgers Health study may help explain why some people are more susceptible to developing drinking problems.
Most families discover inherited genetic mutations after one member develops a health problem unusual to their age. This can prompt younger generations to get genetic testing. But in the case of Cassie Munoz and her family, the scenario was reversed.
Dr. Xavier Salvador and Dr. Carla Garcia from IRB Barcelona, a leading biomedical institute in Spain, presented their groundbreaking discovery on the origins of idiopathic autism鈥攃ases where no known genetic mutation has been identified.
MyOme, a leading clinical innovation whole genomic analysis and polygenic risk modelling (PRS) company announced a strategic partnership with Novi Health, a company focused on delivering personalized and preventative healthcare.
During February鈥檚 AMD Awareness Month, the American Society of Retina Specialists (ASRS) shares the facts about AMD and why it鈥檚 essential to partner with a retina specialist to protect vision.
A team of investigators from Dana-Farber Cancer Institute, The Broad Institute of MIT and Harvard, Google, and Columbia University have created an artificial intelligence model that can predict which genes are expressed in any type of human cell.
The red sea urchin (Mesocentrotus franciscanus) is one of the earth's longest-living animals, reported to live more than 100 years without showing signs of aging.
Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson鈥檚 disease. Researchers identified genetic factors in progression and FDA-approved drugs that can potentially be repurposed for PD treatment. The npj Parkinson鈥檚 Disease report uses an approach called 鈥渟ystems biology,鈥� which uses AI to integrate and analyze multiple different forms of information from genetic, proteomic, pharmaceutical and patient datasets to identify patterns that may not be obvious from analyzing one for of data on its own.
The inherited mutated gene WNT9B, which functions normally in embryonic prostate development, increases risk of adult prostate cancer, according to the Vanderbilt University Medical Center study published in JCO Precision Oncology.
Children鈥檚 Hospital Los Angeles (CHLA), a national leader in advanced pediatric medical care and innovative cell and gene therapy research and treatment, announced today the addition of its 10th cell and gene therapy treatment, establishing CHLA as the pediatric provider offering the most FDA-approved, state-of-the-art cell and gene therapy treatments on the West Coast.
A person鈥檚 lifetime risk for cancer may begin before they are even born, reports a paradigm-shifting study published in Nature Cancer.
The four-year , funded by Cystic Fibrosis Foundation, is a national three-part study of adults 18 years and older who identify as lesbian, gay, bisexual, transgender, queer, intersex, asexual or other sexual/gender minority (LGBTQIA+) with cystic fibrosis.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal 海角社区 keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
